Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.081 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |